Donate to save lives this Breast Cancer Awareness Month.
The purpose of this study is to see if a handheld imaging device (MEprobe) can accurately detect the microscopic presence of cancer in breast surgery patients.
Who is it for?
You may be eligible for this study if you are female, aged 18 or over and have been diagnosed with an invasive or localized breast cancer.
All participants in this study will have a surgical probe take images of the breast tissue during their breast surgery. Your breast surgeon will also send the breast tissue removed during surgery to pathology for routine laboratory testing to determine the characteristics of the breast cancer (including the size of the cancer as well as diagnostic factors such as tumour margins and hormone receptor status). The images from the device will be assessed by a reading centre following the procedure, to ascertain the accuracy of the probe acquired images. The images from the device will not be used to make any treatment decisions.
It is hoped this research will demonstrate that surgical imaging incorporated into the MEprobe is capable of creating high quality images that can be used during breast surgery to identify residual breast cancer and guide future protocols using this device.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at firstname.lastname@example.org
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to email@example.com